Khosla Ventures Acquisition Co. (KVSA) to Combine with Valo Health in $2.3Bn Deal

Khosla (NASDAQ:KVSA) has entered into a definitive agreement to combine with drug discovery platform Valo Health at a firm value of $2.32 billion. Boston-based Valo Health is a technology company built to accelerate the drug discovery and development process using human-centric data and artificial intelligence (AI) tools. The transaction is expected to close in the
Read More